Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(513)
- Endocannabinoid/Endocannabinoid-like(141)
- Fatty Acid Conjugates(10)
- Fatty Acids(483)
- Fatty Alcohols/Aldehydes(15)
- Fatty Amides(75)
- Fatty Esters/Ethers(150)
- Glycerolipids(351)
- Glycerophospholipids(241)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(135)
- Isoprostanes(36)
- Leukotrienes(63)
- Lipid Transport(9)
- Lipid-Based Drug Delivery(178)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(120)
- Other Lipid Kinases(2)
- Polyketides(58)
- Prenol Lipids(19)
- Prostaglandins(462)
- Protein Lipidation(22)
- Reactive O2/N2 Pathways(114)
- Saccharolipids(1)
- Sphingolipids(347)
- Sterol Lipids(263)
- Thromboxanes(13)
- 17β-HSD(5)
- Cat.No. 产品名称 Information
-
GC41924
15(S)-15-methyl Prostaglandin F2α isopropyl ester
15(S)15methyl PGF2α isopropyl ester
Analog of 15(S)-15-methyl PGF2α methyl ester -
GC41923
15(R)-Prostaglandin I2 (sodium salt)
15(R)-PGI2
An isomer of PGI2 -
GC41922
15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester
15epi Bimatoprost isopropyl ester, 15(R)Bimatoprost isopropyl ester, 15(R)17phenyl trinor PGF2α isopropyl ester
A potential impurity of latanoprost -
GC41921
15(R)-15-methyl Prostaglandin A2
15(R)15methyl PGA2
Possible impurity in bulk productions of arbaprostil -
GC41920
15(R),19(R)-hydroxy Prostaglandin F1α
15(R),19(R)hydroxy PGF1α
The inverse isomer of a 19-hydroxylated prostaglandin -
GC41918
14-methyl Pentadecanoic Acid methyl ester
14-甲基十五烷酸甲酯
A methylated fatty acid methyl ester -
GC41917
14-methyl Palmitic Acid
14-甲基十六烷酸
A methylated fatty acid -
GC41916
13-SAHSA
A FAHFA with anti-diabetic potential
-
GC41915
13-POHSA
A FAHFA with anti-diabetic potential
-
GC41914
13-OxoODE
13-KODE
The product of NAD+-dependent dehydrogenase activity on 13-HODE -
GC41913
13-OAHSA
A FAHFA with anti-diabetic potential
-
GC41912
13-methyl Pentadecanoic Acid methyl ester
Methyl 13-methyl Pentadecanoate Acid
A methylated fatty acid methyl ester -
GC41911
13-epi-12-oxo Phytodienoic Acid
13-EPI-12-氧代植物二烯酸
A lipoxygenase metabolite of α-linolenic acid -
GC41910
13-Docosenamide
芥酸酰胺
The amide of docosenoic acid -
GC41908
13C6 Glucosylsphingosine (d18:1)
1-β-D-Glucosyl-1,2,3,4,5,6-13C6-sphingosine, 13C6-Glucosylsphingosine
An internal standard for the quantification of 1-β-D-glucosylsphingosine
-
GC41907
13C C16 Sphingomyelin (d18:1/16:0)
Palmitoyl Sphingomyelin-13C, N-Palmitoyl-D-erythro-Sphingosylphosphorylcholine-13C, SM(d18:1/16:0-13C), Sphingomyelin (d18:1/16:0-13C)
An internal standard for the quantification of C16 sphingomyelin -
GC41906
13,14-epoxy Fluprostenol isopropyl ester
13,14epoxy Travoprost
Travoprost impurity -
GC41905
13,14-dihydro-16,16-difluoro Prostaglandin E1
(11ALPHA)-16,16-二氟-11,15-二羟基-9-氧代-前列烷-1-酸
Analog of PGE1 -
GC41904
13,14-dihydro-15-keto-tetranor Prostaglandin F1β
5β, 7αdihydroxy11ketotetranorProstanoic Acid, 9β13,14dihydro15ketotetranor Prostaglandin F1α, 9β,11αdihydroxy15oxo2,3,4,5tetranorProstanoic Acid
A major urinary metabolite of PGE2 -
GC41903
13,14-dihydro-15-keto-tetranor Prostaglandin F1α
5β, 7αdihydroxy11ketotetranorProstanoic Acid, 9β13,14dihydro15ketotetranor Prostaglandin F1α, 9β,11αdihydroxy15oxo2,3,4,5tetranorProstanoic Acid
Potential metabolite of PGF1α and PGF2α
-
GC41902
13,14-dihydro Prostaglandin F1α
PGFα, 13,14dihydro PGF1α
A potential metabolite of PGF1α -
GC41901
13(Z)-Docosenoic Acid methyl ester
芥酸甲酯
A fatty acid methyl ester -
GC41899
13(S)-HpOTrE
A product of soybean LO-2 metabolism of α-linolenic acid
-
GC41898
13(S)-HOTrE(γ)
A 15-LO product derived from GLA
-
GC41897
13(S)-HOTrE
A 15-LO product derived from GLA
-
GC41895
13(S)-HODE cholesteryl ester
Extracted from atherosclerotic lesions; can be used as a standard
-
GC41894
13(S),14(S)-epoxy Fluprostenol isopropyl ester
Epoxy Derivative 2, 13(S),14(S)epoxy Travoprost
Travoprost impurity -
GC41893
13(R)-HODE cholesteryl ester
Extracted from atherosclerotic lesions; can be used as a standard
-
GC41892
13(R),14(R)-epoxy Fluprostenol isopropyl ester
Epoxy Derivative 1, 13(R),14(R)epoxy Travoprost
Travoprost impurity -
GC41891
12-SAHSA
A FAHFA with anti-diabetic potential
-
GC41890
12-POHSA
A FAHFA with anti-diabetic potential
-
GC41889
12-oxo Stearic Acid methyl ester
12-氧代十八烷酸甲酯
An esterified form of 12-oxo stearic acid -
GC41887
12-OAHSA
A FAHFA with anti-diabetic potential
-
GC41886
12-Doxylstearic Acid
12-氮氧自由基硬脂酸
A hydrophobic spin label -
GC41885
12:0 N-Biotinyl Fatty Acid
N-Biotinyl Dodecanoic Acid
A biotinylated form of lauric acid -
GC41884
12(Z),15(Z)-Heneicosadienoic Acid
C21:2, C21:2n-6,9
A very long-chain polyunsaturated fatty acid -
GC41882
12(S)-HETrE
An inhibitor of platelet activation
-
GC41880
11-keto Fluprostenol
曲伏前列素杂质
A prostaglandin D2/Fluprostenol structural hybrid -
GC41879
11-deoxy-11-methylene-15-keto Prostaglandin D2
11deoxy11methylene15keto PGD2
Stable ligand for the DP1 receptor -
GC41878
11-dehydro-2,3-dinor Thromboxane B2
11dehydro2,3dinor TXB2
A TXB2 urinary metabolite -
GC41877
11-dehydro Thromboxane B3
11dehydro TXB3
A urinary metabolite of TXA3 -
GC41876
11(Z)-Eicosenoic Acid methyl ester
顺-11-二十烯酸甲酯
A natural derivative of 11(Z)-eicosenoic acid -
GC41875
11(Z),14(Z)-Eicosadienoic Acid methyl ester
(11Z,14Z)-11,14-二十碳二烯酸甲酯
A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid -
GC41874
11(Z),14(Z),17(Z)-Eicosatrienoic Acid methyl ester
An ester form of the ω-3 PUFA
-
GC41873
10-Thiastearic Acid
A stearoyl CoA desaturase inhibitor
-
GC41872
10-SAHSA
A FAHFA with anti-diabetic potential
-
GC41871
10-POHSA
A FAHFA with anti-diabetic potential
-
GC41870
10-PAHSA 13C4
An internal standard for the quantification of 10-PAHSA
-
GC41869
10-OAHSA
A FAHFA with anti-diabetic potential
-
GC41868
10-Nitrooleate
10-硝基油酸,CXA-10
A novel endogenous lipid signalling molecule